419 related articles for article (PubMed ID: 36108371)
1. Patchouli alcohol ameliorates the learning and memory impairments in an animal model of Alzheimer's disease via modulating SIRT1.
Xu QQ; Su ZR; Hu Z; Yang W; Xian YF; Lin ZX
Phytomedicine; 2022 Nov; 106():154441. PubMed ID: 36108371
[TBL] [Abstract][Full Text] [Related]
2. Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer's disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway.
Xu QQ; Su ZR; Yang W; Zhong M; Xian YF; Lin ZX
J Neuroinflammation; 2023 Jan; 20(1):19. PubMed ID: 36717922
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3
Yang W; Liu Y; Xu QQ; Xian YF; Lin ZX
Oxid Med Cell Longev; 2020; 2020():4754195. PubMed ID: 32963694
[TBL] [Abstract][Full Text] [Related]
4. Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer's Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway.
Hasan N; Zameer S; Najmi AK; Parvez S; Akhtar M
Neurotox Res; 2022 Apr; 40(2):432-448. PubMed ID: 35192144
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Aβ
Singh L; Singh S
Neurosci Lett; 2023 Mar; 799():137090. PubMed ID: 36690059
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic effects of sporoderm-removed Ganoderma lucidum spores in a rat model of streptozotocin-induced sporadic Alzheimer's disease.
Zhao HL; Cui SY; Qin Y; Liu YT; Cui XY; Hu X; Kurban N; Li MY; Li ZH; Xu J; Zhang YH
J Ethnopharmacol; 2021 Apr; 269():113725. PubMed ID: 33352241
[TBL] [Abstract][Full Text] [Related]
7. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model.
Guo Z; Chen Y; Mao YF; Zheng T; Jiang Y; Yan Y; Yin X; Zhang B
Sci Rep; 2017 Apr; 7():45971. PubMed ID: 28382978
[TBL] [Abstract][Full Text] [Related]
9. Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer's Disease.
Zhang H; Wang D; Gong P; Lin A; Zhang Y; Ye RD; Yu Y
J Alzheimers Dis; 2019; 67(1):169-179. PubMed ID: 30475772
[TBL] [Abstract][Full Text] [Related]
10. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
[TBL] [Abstract][Full Text] [Related]
11. AMPK activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats.
Du LL; Chai DM; Zhao LN; Li XH; Zhang FC; Zhang HB; Liu LB; Wu K; Liu R; Wang JZ; Zhou XW
J Alzheimers Dis; 2015; 43(3):775-84. PubMed ID: 25114075
[TBL] [Abstract][Full Text] [Related]
12. Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.
Salkovic-Petrisic M; Knezovic A; Osmanovic-Barilar J; Smailovic U; Trkulja V; Riederer P; Amit T; Mandel S; Youdim MB
Life Sci; 2015 Sep; 136():108-19. PubMed ID: 26159898
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol ameliorates learning and memory impairments induced by bilateral hippocampal injection of streptozotocin in mice.
Wei YD; Chen XX; Yang LJ; Gao XR; Xia QR; Qi CC; Ge JF
Neurochem Int; 2022 Oct; 159():105385. PubMed ID: 35843421
[TBL] [Abstract][Full Text] [Related]
14. The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD.
Li C; Liu W; Li X; Zhang Z; Qi H; Liu S; Yan N; Xing Y; Hölscher C; Wang Z
Brain Behav; 2020 Mar; 10(3):e01505. PubMed ID: 31960630
[TBL] [Abstract][Full Text] [Related]
15. Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer's disease rat model.
Zhu L; Hou XJ; Che XH; Zhou TS; Liu XQ; Wu CF; Yang JY
Acta Pharmacol Sin; 2021 Sep; 42(9):1401-1408. PubMed ID: 33277592
[TBL] [Abstract][Full Text] [Related]
16. Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β pathway in streptozotocin-induced alzheimer rat model.
Gao C; Liu Y; Jiang Y; Ding J; Li L
Brain Pathol; 2014 Apr; 24(3):261-9. PubMed ID: 24329968
[TBL] [Abstract][Full Text] [Related]
17. A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model.
Shi L; Zhang Z; Li L; Hölscher C
Behav Brain Res; 2017 Jun; 327():65-74. PubMed ID: 28342971
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
[TBL] [Abstract][Full Text] [Related]
19. Activation of sirtuin 1 attenuates cerebral ventricular streptozotocin-induced tau hyperphosphorylation and cognitive injuries in rat hippocampi.
Du LL; Xie JZ; Cheng XS; Li XH; Kong FL; Jiang X; Ma ZW; Wang JZ; Chen C; Zhou XW
Age (Dordr); 2014 Apr; 36(2):613-23. PubMed ID: 24142524
[TBL] [Abstract][Full Text] [Related]
20. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis.
Saleh SR; Abd-Elmegied A; Aly Madhy S; Khattab SN; Sheta E; Elnozahy FY; Mehanna RA; Ghareeb DA; Abd-Elmonem NM
Int J Pharm; 2024 Jun; 658():124218. PubMed ID: 38734273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
